Joseph J. Stroble practices in the firm’s Litigation Practice Group and is a member of BABC’s Life Sciences Industry Team. Jay has a diverse, national litigation practice. He is experienced with handling large matters which are electronic discovery intensive. He focuses throughout discovery on preparing cases for trial, with a particular emphasis on company witness and expert witness development.
His areas of practice include class action litigation, product liability litigation, pharmaceutical and medical device litigation, commercial litigation, and professional malpractice defense.
His litigations of note include In re Xarelto (Rivaroxaban) Products Liability Litigation (U.S. District Court, E. District of Louisiana); In re: Genetically Modified Rice Litigation (U.S. District Court, E. District of Missouri); In re Syngenta AG MIR162 Corn Litigation (U.S. District Court, Kansas); In re: Bextra and Celebrex Marketing Sales Practices and Product Liability Litigation (U.S. District Court, N. District of California); In re: Phenylpropanolamine Products Liability Litigation (U.S. District Court, W. District of Washington); and In re: Prempro Products Liability Litigation (U.S. District Court, E. District of Arkansas).
Jay's representative clients include Bayer Corporation, Pfizer Inc., Bristol-Myers Squibb Company, and GlaxoSmithKline plc.